Study guide

5.3 Discipline & Unprofessional Conduct

Minnesota MPJE Pharmacy Jurisprudence

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the Minnesota MPJE 1.2 NABP Competency Areas & Weights 1.3 How to Use This Guide & Study Strategy

2 Federal Controlled Substances Foundations

2.1 CSA Schedules I–V & MN Alignment 2.2 DEA Registration, Forms 222/106/41 & Security 2.3 Federal CS Prescription Rules (CII–CV) 2.4 Inventories, Recordkeeping & Theft/Loss

3 Federal Drug Regulation, Privacy & Supply Chain

3.1 FD&C Act, Legend vs OTC, Misbranding & Adulteration 3.2 OBRA '90, Medicaid DUR & Federal Counseling Floor 3.3 HIPAA Privacy for Pharmacy 3.4 DSCSA & Drug Supply Chain Integrity

4 MN Board, Licensure & Eligibility

4.1 Minnesota Board of Pharmacy Authority & Sources of Law 4.2 Pharmacist Licensure by Exam & Score Transfer 4.3 License Transfer (Reciprocity) & Background Checks 4.4 Interns, Preceptors & 1,600-Hour Experience

5 Renewal, CE, PIC & Discipline

5.1 License Renewal & 30-Hour Biennial CE 5.2 Pharmacist-in-Charge Duties 5.3 Discipline & Unprofessional Conduct 5.4 HPSP, Impaired Practitioners & Mandatory Reporting

6 Technicians, Interns & Supervision

6.1 Technician Registration, Training & CE 6.2 Supervision Ratios (Statute 151.102 & Rule 6800.3850) 6.3 Intern Scope, Delegation & Certification of Accuracy

7 Prescription Authority & Validity

7.1 Who May Prescribe in Minnesota 7.2 Prescription Content & Validity Requirements 7.3 Controlled Substance Prescribing (Chapter 152 + Federal) 7.4 Refills, Partial Fills & Quantity Limits

8 Advanced MN Pharmacist Practice

8.1 Collaborative Practice Agreements & Medication Therapy Management 8.2 Pharmacist Prescriptive Authority (Minn. Stat. 151.37) 8.3 Immunizations & Vaccine Administration 8.4 Drug Administration & Therapy Management

9 Counseling, DUR & Patient Safety

9.1 Patient Counseling Requirements (Rule 6800.0910) 9.2 Prospective Drug Utilization Review 9.3 Returning & Reusing Drugs (Rule 6800.2700)

10 MN PMP & Opioid Public-Health Laws

10.1 Minnesota PMP Overview, Reporting & Pharmacist Use 10.2 Naloxone Access, Steve’s Law & Opioid Antagonists 10.3 Legitimate Medical Purpose & Red Flags

11 Dispensing: Transfers, Labels & Substitution

11.1 Prescription Transfers Between Pharmacies 11.2 Labeling & Packaging of Dispensed Drugs 11.3 Generic Substitution & Product Selection 11.4 Emergency Dispensing, OTC/BTC & Pseudoephedrine

12 Pharmacy Operations & Facilities

12.1 Pharmacy Permits, Classifications & Inspections 12.2 Security, Delivery & Work Conditions 12.3 Operational Recordkeeping & Inventories 12.4 Central Fill, Centralized Processing & Automation

13 Compounding & Hazardous Drugs

13.1 Sterile, Nonsterile & Hazardous Compounding 13.2 Minnesota Compounding Rules & Beyond-Use Dates

14 Test-Day Strategy & Final Review

14.1 When Minnesota Law Is Stricter Than Federal Law 14.2 Test-Day Strategy & Common Traps

5.3 Discipline & Unprofessional Conduct

Key Takeaways Explain This Topic AI

Minn. Stat. 151.071 authorizes Board sanctions including denial, nonrenewal, revocation, suspension, practice limitations/conditions, civil penalties (generally up to $10,000 per violation), and reprimand.

Grounds for discipline include fraud, felony conduct related to practice, out-of-state discipline, unprofessional/unethical practice, impairment, confidentiality breaches, fee-splitting, failure to report, practice on a lapsed license, and HPSP termination other than successful completion.

Rule 6800.2250 lists unprofessional conduct for pharmacists and pharmacies, including deceptive advertising claims, kickbacks, discrimination, counseling avoidance, confidentiality breaches, dangerous practice, and certain diversion-related acts.

Board discipline is a public consumer-protection tool; license verification and public disciplinary records are how patients and employers discover sanctions.

Temporary suspension authority exists when continued practice or operation would create a serious risk of harm to the public, with expedited hearing timelines.

Last updated: July 2026

5.3 Discipline & Unprofessional Conduct

Quick Answer: The Minnesota Board of Pharmacy disciplines licensees under Minn. Stat. 151.071 (sanctions and statutory grounds) and defines many practice failures as unprofessional conduct under Rule 6800.2250 . Sanctions range from reprimand and civil penalties (generally up to $10,000 per separate violation) to suspension, revocation, nonrenewal, and practice limitations . Disciplinary outcomes are public through Board license verification. On the MPJE, connect the vignette’s misconduct to the correct ground + sanction logic , not to private employer HR only.

Discipline is how the Board protects the public when CE, PIC systems, controlled-substance rules, or professional ethics fail. This section is pure Area 1 Licensure/Personnel jurisprudence with heavy practice crossover.

Forms of Disciplinary Action (§151.071, subd. 1)

When the Board finds prohibited conduct under subdivision 2, it may impose one or more of the following:

  • Deny issuance of a license or registration
  • Refuse to renew a license or registration
  • Revoke the license or registration
  • Suspend the license or registration

Impose limitations/conditions (examples: practice only in designated settings; limited scope; retraining/rehabilitation; practice under supervision; participation in a diversion/monitoring program such as that established under §214.31 (HPSP); demonstration of knowledge/skills by examination or review)

Civil penalty — generally not exceeding $10,000 for each separate violation (higher caps exist for certain statutory schemes outside ordinary pharmacy practice, e.g., specified 62J violations); penalty amount may be set to remove economic advantage, deter similar violations, or reimburse investigation/hearing costs

Reprimand

Exam tip: Sanctions are stackable (“one or more”). A case can combine suspension + conditions + civil penalty + reprimand depending on facts.

High-Yield Grounds (§151.071, subd. 2)

You do not need to recite all 25 clauses verbatim, but you must recognize the major buckets:

  • Bucket Examples from §151.071 subd. 2
  • Entry integrity Failure to meet qualifications; fraud/cheating in licensure or exam subversion
  • Criminal conduct Felony reasonably related to pharmacy practice (with related definitions of conviction)

Sister-board / out-of-state actions Discipline or refusal of license elsewhere; failure to report charges/allegations as required

Rule & law violations Violating Board orders, chapter 151, Board rules, or other laws reasonably related to pharmacy

Public-harm ethics Unethical conduct; conduct likely to deceive/defraud/harm; willful/careless disregard for patient safety; professionally incompetent practice ( actual injury need not be proven )

Unlicensed practice aid Aiding unlicensed practice (proper tech/intern supervision is not a violation)

Capacity adjudications Certain court adjudications (e.g., mental illness, chemical dependency designations as listed) with automatic suspension consequences

Unprofessional conduct For pharmacists/interns, unprofessional conduct as specified in Board rules; tech analogs

Pharmacy without pharmacist Operating a pharmacy without a pharmacist present/on duty except under Board-approved variance

  • Impairment Inability to practice safely due to illness, alcohol/drugs/chemicals, or mental/physical condition
  • Privacy & records Revealing privileged communications; improper patient-record management
  • Financial misconduct Fee-splitting/kickbacks/referral remuneration; abusive/fraudulent billing
  • Sexual misconduct Sexual or seductive conduct with patients as defined
  • Process duties Failure to make required reports ( §151.072 ) or cooperate with Board investigation

False patient-care info Knowingly providing false/misleading information related to patient care (with limited therapeutic exceptions)

Lapsed credentials Practicing pharmacy under a lapsed or nonrenewed license (and analogs for techs/interns/facilities)

  • HPSP failure Termination/discharge from HPSP for reasons other than satisfactory completion
  • Why “no actual injury required” matters

For professionally incompetent or dangerous practice grounds, the Board need not wait for a dead or injured patient. Creating unnecessary danger can be enough. That matches the public-protection purpose of pharmacy regulation.

Rule 6800.2250 — Unprofessional Conduct Catalog

Rule 6800.2250 Subp. 1 states that unprofessional conduct includes, but is not limited to , acts by a pharmacist or pharmacy such as:

  • A. Public assertions of material claims of professional superiority that cannot be substantiated
  • B. Publishing or circulating false, misleading, or deceptive statements about pharmacy practice

C. Refusing to compound or dispense prescription orders that may reasonably be expected to be compounded/dispensed—subject to limited statutory exceptions (e.g., cited reproductive/conscience-related statutes in the rule text)

D. Kickbacks / fee-splitting / special charges in exchange for professional pharmaceutical services, including furnishing money/goods/services free or below cost to induce placement of business with a pharmacy (with limited cost-justified discount competition language)

E. Discrimination among patients based on protected characteristics listed in the rule

F. Refusing consultation , attempting to circumvent consulting requirements, or discouraging patients from receiving consultation about contents, therapeutic values, uses, and prices of legend/nonlegend drugs, chemicals, or poisons

  • G. Requiring organization membership as a condition of obtaining pharmacist professional services
  • H. Violating pharmacy-related laws/rules of the state, political subdivisions, the Board, or the United States

I. Divulging professional pharmaceutical services rendered to a patient without consent or court order (with limited pharmacy-to-pharmacy / patient / physician-therapy communication allowances)

J. Serving as an institutional consultant without providing services consistent with accepted principles and law

K. Engaging in pharmacy practice that is a danger to health, welfare, or safety , including substantial departure from the ordinary standard of care that harms or could harm a patient

Additional subparts you should not ignore

Subp. 2 (improper advertising of legend drug prices): Price info may be provided only by a pharmacy under strict conditions—no safety/effectiveness/indication claims, no Schedule II–IV CS references in the ad framework stated, and termination date of listed prices must appear.

Subp. 3 (accessories to illegal drug traffic): Selling/giving accessories or chemicals found in illegal drug traffic when the pharmacist knows or should have known of intended illegal use.

Subp. 4 (drug diversion of discounted hospital/charity stock): Selling/purchasing/trading drugs bought by hospitals/health care entities or donated/supplied at reduced price to charities—subject to listed exceptions (common control, emergency medical reasons, ordinary Rx dispensing, certain group purchasing arrangements).

Public Nature of Discipline

Board discipline is not a private HR memo. Minnesota’s licensing system is built so that license status and public disciplinary history can be checked through Board verification tools used by employers, other boards, and the public. On exam items:

  • Expect that serious Board actions are discoverable
  • Do not assume a settlement is automatically secret

Understand that out-of-state discipline can become Minnesota grounds and that failure to report required matters is itself a ground

Always confirm the current public look-up process on the Board website, but treat public verification of discipline as the exam default for consumer-protection logic.

Temporary Suspension for Serious Risk

§151.071 includes temporary suspension pathways (pharmacists; interns/techs/researchers; pharmacies and certain facilities) when the Board finds a statute/rule violation and continued practice/operation would create a serious risk of harm to the public . Features to remember:

  • May issue without a prior hearing
  • Takes effect on written notice specifying the violated statute/rule
  • Remains until a final order after hearing

Board schedules an APA disciplinary hearing with at least 20 days’ notice , hearing to begin no later than 30 days after the suspension order

This is the emergency brake when ordinary investigation timelines would leave the public unprotected.

Process Edges That Appear on Exams

Name/address currency: Licensees must maintain current name/home address with the Board and notify of changes within 30 days ; facilities have their own notice rules (including advance notice for in-state moves). Failure to maintain address while under investigation/order can support suspension.

Mental/physical examination: If probable cause supports an impairment ground, the Board may direct examination; failure to submit can be treated as an admission (with limited exceptions).

Limitation period: Board proceedings generally must commence within seven years of the misconduct (with stated exceptions).

Tax clearance: Renewal/issuance can be blocked for certain delinquent state taxes of $500+ until clearance.

Mapping Vignettes to Law

  • Vignette Likely legal hook
  • Pharmacist discourages all counseling to “speed the line” 6800.2250 F + counseling rules
  • Pharmacy pays LTC facility for exclusive referral of scripts 6800.2250 D / fee-splitting grounds

Staff pharmacist diverts oxycodone; continues working impaired Impairment grounds; reporting duties; possible temporary suspension

  • Pharmacist practices three months after nonrenewal §151.071 lapsed-license ground
  • False superiority ads: “Only pharmacists smarter than MDs” 6800.2250 A/B
  • PIC ignores 30-day deficiency response PIC rule + law/rule violation grounds
  • Licensee fired from HPSP for noncompliance §151.071 subd. 2(24)
  • Study Checklist

List the seven sanction types in subd. 1.

Explain why danger without injury can still be discipline.

Recite at least six Rule 6800.2250 unprofessional acts, including counseling avoidance and kickbacks.

State that discipline is public via verification .

Describe temporary suspension’s serious-risk trigger and 20/30-day hearing timing concept.

Section 5.4 covers the alternative-to-discipline monitoring path — HPSP —and the mandatory reporting web that feeds both HPSP and the Board.